The angiogenesis pathway, the PI3K/Akt/mTOR pathway and glucose metabolism are under thorough investigation in studies, but currently there is no approved targeted therapy for this cancer beyond hormonal therapy [82]. The gene discussed is AKT1; the disease is cancer.